Cabinet Approves FDI Of Up To Rs 9,589 Crore In Suven Pharma by Cyprus-base Berhyanda

The government on Wednesday approved foreign direct investment of up to Rs 9,589 crore in Suven Pharmaceuticals Ltd. by Cyprus-base Berhyanda Ltd.

The approval is for the acquisition of up to 76.1% of the equity shares of Suven Pharma by Berhyanda Ltd., based in Cyprus, according to a release by the Cabinet Committee on Economic Affairs on Wednesday.

This would bring the total foreign investment to 90.1% in Suven Pharma.

Related Keywords

United States ,Cyprus ,India ,American ,Suven Pharma ,Cabinet Committee On Economic Affairs ,Advent Group ,Advent International Corp ,Berhyanda Ltd ,Competition Commission Of India ,Indian Company ,Suven Pharmaceuticals Ltd ,Suven Pharmaceuticals ,Cyprus Based Berhyanda ,Cabinet Committee ,Economic Affairs ,Competition Commission ,Foreign Direct Investment Policy ,Advent India ,Foreign Direct Investment ,Bqmetered ,